Our observation of increased PPP engagement in circulating CD8+ T cells isolated from patients with MS, coupled with evidence of a transcriptional program that is consistent with PPP activation in CD8+ T cells isolated from the CSF of patients with MS (Figures 2 and 11), suggests that this pathway is pathogenically relevant. The gene discussed is CD8A; the disease is myeloid sarcoma.